| Income Statement |
| Total Revenue | 105.47M |
|
| Revenues (USD) | 105.47M |
| Cost of Revenue | 43.21M |
| Gross Profit | 62.27M |
| Operating Expenses | 57.46M |
| Research and Development Expense | 571.00K |
| Selling, General and Administrative Expense | 56.49M |
| Operating Income | 4.80M |
| Interest Expense | 1.25M |
| Income Tax Expense | 949.00K |
| Net Income | 1.36M |
| Net Income Common Stock | 1.36M |
| Net Income Common Stock (USD) | 1.36M |
| Consolidated Income | 1.36M |
| Earnings per Basic Share | 0.01 |
| Earnings per Basic Share (USD) | 0.01 |
| Earnings per Diluted Share | 0.01 |
| Earning Before Interest & Taxes (EBIT) | 3.56M |
| Earning Before Interest & Taxes (USD) | 3.56M |
| Weighted Average Shares | 91.79M |
| Weighted Average Shares Diluted | 93.92M |
| Balance Sheet |
| Cash and Equivalents | 132.53M |
| Cash and Equivalents (USD) | 132.53M |
| Trade and Non-Trade Receivables | 95.75M |
| Current Assets | 274.13M |
| Property, Plant & Equipment Net | 30.37M |
| Total Assets | 397.10M |
| Debt Current | 4.82M |
| Total Debt | 78.58M |
| Current Liabilities | 324.39M |
| Debt Non-Current | 73.77M |
| Total Liabilities | 419.67M |
| Accumulated Retained Earnings (Deficit) | -200.02M |
| Accumulated Other Comprehensive Income | -5.51M |
| Shareholders Equity | -22.57M |
| Shareholders Equity (USD) | -22.57M |
| Assets Non-Current | 122.97M |
| Total Debt (USD) | 78.58M |
| Deferred Revenue | 277.33M |
| Liabilities Non-Current | 95.28M |
| Trade and Non-Trade Payables | 4.97M |
| Tax Assets | 58.98M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.35M |
| Net Cash Flow from Financing | -10.60M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 12.22M |
| Capital Expenditure | -648.00K |
| Issuance (Purchase) of Equity Shares | 337.00K |
| Issuance (Repayment) of Debt Securities | -10.94M |
| Net Cash Flow from Investing | -648.00K |
| Net Cash Flow from Operations | 24.52M |
| Effect of Exchange Rate Changes on Cash | -1.06M |
| Share Based Compensation | 2.66M |